Home/Filings/4/0001493152-24-022038
4//SEC Filing

Jones Mitchell Lawrence 4

Accession 0001493152-24-022038

CIK 0001357459other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 7:44 PM ET

Size

15.5 KB

Accession

0001493152-24-022038

Insider Transaction Report

Form 4
Period: 2024-05-28
Jones Mitchell Lawrence
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-281,5550 total
    Common Stock (1,555 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-28+2,7353,568 total
  • Exercise/Conversion

    Common Stock, par value $0.01

    2024-05-28+1,5554,313 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-282,7350 total
    Common Stock (2,735 underlying)
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-28$4.76/sh810$3,8562,758 total
  • Tax Payment

    Common Stock, par value $0.01

    2024-05-28$4.76/sh461$2,1943,852 total
Footnotes (7)
  • [F1]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.
  • [F2]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.
  • [F3]Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
  • [F4]Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.
  • [F5]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  • [F6]This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.
  • [F7]This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

Documents

1 file

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001993292

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 7:44 PM ET
Size
15.5 KB